Influenza is a viral infection of the respiratory system and is characterized by symptoms such as headache, muscle aches, congestion, fever, runny nose, and fatigue. It is majorly responsible for seasonal flu epidemics each year. It is a contagious infection, which is transmissible through the sneezing and coughing of an infected person. Vaccine serves as an effective method for the prevention of influenza. Additionally, several factors such as advancements in existing vaccines, development of new vaccines, minimal side effects, funding and investments by companies in R&D activities, and an increase in the government initiatives to ensure the well-being of the population are contributing to the further growth of the global influenza vaccine market.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6227
The availability of several influenza vaccines that have been prequalified by the WHO for purchase by the UN agencies is significantly contributing to the proliferation of the global influenza vaccine market. An increase in the routine immunization programs in the developed, as well as developing countries, is creating lucrative opportunities for the further progress of the global market.
Some of the key insights about the global influenza vaccine market are given below:
- The global influenza vaccine market has five key regions viz. Latin America, North America, Europe, Middle East and Africa, and Asia Pacific that provide us with a better understanding of its working dynamics. Currently, the market is expected to be dominated by North America owing to several factors such as the advancements of vaccine administration, emergence of new vaccines, focus of government on immunization programs, and the prevalence of influenza in the region.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6227
- The leading players in the global market for influenza vaccine are expected to witness strong competition in the coming years of the forecast period. Some of the leading brands in the global market include names such as AstraZeneca Plc, Biodiem, CSL Limited, F. Hoffman-La Roche Ltd, Emergent Biosolutions, Gamma Vaccines Pty Ltd, GlaxoSmithKline Plc., Merck & Co., Inc. (Merck Sharp & Dohme Corp), Pfizer, Inc., Novartis AG, Sanofi Pasteur SA, and Sinovac Biotech Ltd among others.